Kinetics of response to conventional treatment in patients with pemphigus vulgaris

Archives of Dermatology

Volumn 144, Issue 5, 2008, Pages 682-683

  Czernik, Annette ^b   Bystryn, Jean Claude ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG DOSE INCREASE; HUMAN; INFECTION; KINETICS; LETTER; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; REMISSION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOCORTICOIDS; HUMANS; PEMPHIGUS; PREDNISONE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 44249095823     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.5.682     Document Type: Letter

References (4)

1. Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol. 2000;42(3):422-427.
2. Bystryn JC, Rudolph JL. Pemphigus. Lancet. 2005;366(9479):61-73.
3. National Cancer Institute. Common terminology criteria for adverse events v3.0 (CTCAE). http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed June 19, 2007.
4. Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari HC. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. Arch Dermatol. 2003;139(6):739-742.